Skip to main contentSkip to navigation
Sirius Investors
BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

BBIO
NASDAQHealthcare

Revenue Analysis - BBIO

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

BBIO Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$180.6M

Royalty

0.0% of total revenue

$9.5M

License and Service

0.0% of total revenue

$4.4M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
License and Service
Net Product Revenue
Product
Royalty
Royalty Revenue
3/31/2026$4.4M$0$180.6M$9.5M$0
12/31/2025$120.0M$0$254.3M$7.1M$0
9/30/2025$8.3M$0$108.1M$4.3M$0
6/30/2025$0$71.5M$0$0$1.6M
3/31/2025$0$36.7M$0$0$0
3/31/2023$1.8M$0$0$0$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Royalty+33.7%
Declining Segments
License and Service-96.3%
Product-29.0%

Earnings Reports

Want to see how BBIO's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports